XML 26 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Dec. 31, 2011
Mar. 31, 2012
Restricted Stock [Member]
Mar. 31, 2011
Restricted Stock [Member]
Dec. 31, 2011
Performance Share Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Awarding of performance shares earned payable in cash           40.00%
Number of shares authorized for grant 12,500,000          
Shares available for future issuance 1,911,768          
Options Roll Forward            
Shares outstanding under option, Beginning Balance 2,220,000          
Weighted average exercise price, Beginning Balance $ 29.36          
Shares outstanding under option, Exercised (602,000)          
Shares outstanding under option, Exercised, Weighted average exercise price $ 26.97          
Shares outstanding under option, Ending Balance 1,618,000          
Weighted average exercise price, Ending Balance $ 30.19          
Weighted average remaining contractual term 4.0   4.1      
Aggregate intrinsic value, outstanding $ 87.6   $ 76.3      
Restricted stock compensation expense            
Restricted stock expense       4.7 2.9  
Restricted stock expense, net of tax       3.5 2.2  
Status of nonvested restricted stock            
Nonvested shares subject to restriction, Beginning Balance 1,430,000          
Nonvested shares subject to restriction, weighted average exercise price $ 39.02          
Restricted shares granted to employees 327,000     326,638    
Granted shares subject to restriction, weighted average exercise price $ 78.27          
Shares subject to restriction, Vested (631,000)          
Vested shares subject to restriction, weighted average exercise price $ 26.42          
Shares subject to restriction, Forfeited (23,000)          
Forfeited shares subject to restriction, weighted average exercise price $ 42.49          
Nonvested shares subject to restriction, Ending Balance 1,103,000          
Nonvested shares subject to restriction, weighted average exercise price $ 57.79          
Awarding of performance shares earned payable in common stock           60.00%
Performance Share Plan Expense Associated with Liability   $ 10.6